The Putatively Specific Synthetic REV-ERB Agonist SR9009 Inhibits IgE- and IL-33-Mediated Mast Cell Activation Independently of the Circadian Clock
Open Access
- 14 December 2019
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 20 (24), 6320
- https://doi.org/10.3390/ijms20246320
Abstract
The cell-autonomous circadian clock regulates IgE- and IL-33-mediated mast cell activation, both of which are key events in the development of allergic diseases. Accordingly, clock modifiers could be used to treat allergic diseases, as well as many other circadian-related diseases, such as sleep and metabolic disorders. The nuclear receptors REV-ERB-α and -β (REV-ERBs) are crucial components of the circadian clockwork. Efforts to pharmacologically target REV-ERBs using putatively specific synthetic agonists, particularly SR9009, have yielded beneficial effects on sleep and metabolism. Here, we sought to determine whether REV-ERBs are functional in the circadian clockwork in mast cells and, if so, whether SR9009 affects IgE- and IL-33-mediated mast cell activation. Bone marrow-derived mast cells (BMMCs) obtained from wild-type mice expressed REV-ERBs, and SR9009 or other synthetic REV-ERBs agonists affected the mast cell clockwork. SR9009 inhibited IgE- and IL-33-mediated mast cell activation in wild-type BMMCs in association with inhibition of Gab2/PI3K and NF-κB activation. Unexpectedly, these suppressive effects of SR9009 were observed in BMMCs following mutation of the core circadian gene Clock. These findings suggest that SR9009 inhibits IgE- and IL-33-mediated mast cell activation independently of the functional circadian clock activity. Thus, SR9009 or other synthetic REV-ERB agonists may have potential for anti-allergic agents.Keywords
This publication has 28 references indexed in Scilit:
- REV-ERB agonism suppresses osteoclastogenesis and prevents ovariectomy-induced bone loss partially via FABP4 upregulationThe FASEB Journal, 2018
- Pharmacological activation of REV-ERBs is lethal in cancer and oncogene-induced senescenceNature, 2018
- Clock-dependent temporal regulation of IL-33/ST2-mediated mast cell responseAllergology International, 2017
- Circadian time signatures of fitness and diseaseScience, 2016
- Circadian regulation of allergic reactions by the mast cell clock in miceJournal of Allergy and Clinical Immunology, 2013
- Rev-erb-α modulates skeletal muscle oxidative capacity by regulating mitochondrial biogenesis and autophagyNature Medicine, 2013
- Rev-Erbs repress macrophage gene expression by inhibiting enhancer-directed transcriptionNature, 2013
- Interleukin‐33 in allergyAllergy, 2012
- Regulation of circadian behaviour and metabolism by synthetic REV-ERB agonistsNature, 2012
- Mechanisms of mast cell signaling in anaphylaxisJournal of Allergy and Clinical Immunology, 2009